sigma plot 2002 windows version 8.02 (SYSTAT)
SYSTAT is a verified supplier 
90
Structured Review
SYSTAT
sigma plot 2002 windows version 8.02
Sigma Plot 2002 Windows Version 8.02, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigma+plot+2002/sigma+plot+2002+windows+version+8+02/pm21732726-104-38-41
Average 90 stars, based on 1 article reviews
Sigma Plot 2002 Windows Version 8.02, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigma+plot+2002/sigma+plot+2002+windows+version+8+02/pm21732726-104-38-41
Average 90 stars, based on 1 article reviews
sigma plot 2002 windows version 8.02 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Concentration Assay:Article Title: Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies. Article Snippet: Study Objective.. To assess the pharmacokinetic profile of palifermin after intravenous dosing with either a collapsed dose of 180 μg/kg/day for 1 day or a standard dose of 60 μg/kg/day for 3 days, before and after myeloablative chemoradiotherapy and peripheral blood progenitor cell (PBPC) transplantation.. Design. Generated:Article Title: Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies. Article Snippet: Study Objective.. To assess the pharmacokinetic profile of palifermin after intravenous dosing with either a collapsed dose of 180 μg/kg/day for 1 day or a standard dose of 60 μg/kg/day for 3 days, before and after myeloablative chemoradiotherapy and peripheral blood progenitor cell (PBPC) transplantation.. Design. Software:Article Title: Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies. Article Snippet: Study Objective.. To assess the pharmacokinetic profile of palifermin after intravenous dosing with either a collapsed dose of 180 μg/kg/day for 1 day or a standard dose of 60 μg/kg/day for 3 days, before and after myeloablative chemoradiotherapy and peripheral blood progenitor cell (PBPC) transplantation.. Design. |